ArticleCancer research2013

Combination of antibody that inhibits ligand-independent HER3 dimerization and a p110α inhibitor potently blocks PI3K signaling and growth of HER2+ breast cancers.

Joan T Garrett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.